# NCT01336894 (NCT01336894)

> Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: high-risk stage I non-small cell lung cancer

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01336894
- Phase: PHASE3
- Status: TERMINATED
- Sponsor: Alliance for Clinical Trials in Oncology
- Conditions: Lung Cancer
- Interventions: therapeutic conventional surgery; iodine I 125; stereotactic body radiation therapy
- Enrollment: 13
- Primary outcome: 3-year Overall Survival (OS) Rate

## Indexed commentary on NCT01336894 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=nct01336894